哈药集团控股股东部分股份解除质押并新增质押

Core Viewpoint - Harbin Pharmaceutical Group Co., Ltd. announced significant share pledge activities by its controlling shareholder, Harbin Pharmaceutical Group, which may impact the company's financial structure but is deemed manageable and without substantial effect on the company [1] Group 1: Shareholding and Pledge Details - Harbin Pharmaceutical Group holds 46.58% of the company's shares [1] - On October 10, 2025, Harbin Pharmaceutical Group will release a pledge on 287,581,686 shares, which accounts for 24.51% of its holdings and 11.42% of the total share capital [1] - On October 13, 2025, Harbin Pharmaceutical Group pledged 205,000,000 shares to Ping An Bank Harbin Branch, representing 17.47% of its holdings and 8.14% of the total share capital [1] Group 2: Cumulative Pledge and Financial Status - After these transactions, the cumulative pledged shares by Harbin Pharmaceutical Group will amount to 71.96% of its holdings and 33.52% of the total share capital [1] - The financial and credit status of Harbin Pharmaceutical Group is reported to be good, indicating that the pledge risk is controllable [1] - The current share pledges are stated to have no substantial impact on the company [1]